Device Trial Radar · NCT01693211
Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye Centre
Last checked: Nov 20, 2026Latest source record: Jul 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Technolas Perfect Vision GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 26, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, randomized study evaluating the circularity of the anterior capsulotomy performed by the VICTUS femtosecond work station (Group A) versus the manual capsulotomy (Group B) of a minimum of 22 eyes and maximum of 30 eyes per group diagnosed with cataract, scheduled to undergo removal by phacoemulsification with intraocular lens implantation in SNEC. The primary study end point is to determine if the circularity of the created rhexis is better in Group A as compared to Group B. The secondary study end point is to determine the diameter of rhexis is more precise and reproducible in Group A as compared to Group B.
Conditions
- Primary Disease: Cataract
Interventions
Femtosecond Laser (VICTUS™ Femtosecond Laser Platform)Device
Capsulotomy and pre-fragmentation of the nucleus are performed by the femtosecond laser.
Manual (CCC technique with Utrata forceps)Device
Capsulorhexis and pre-fragmentation are performed manually.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Circularity of created rhexisTime frame: intraoperative
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Singapore National Eye Centre
Singapore, Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.